TGFB1 and cancer: Uncontrolled TGF-β signaling pathways have been linked to fibrosis [4, 5], cancers [4, 5], atherosclerosis [6], systemic sclerosis [7], early-stage myelodysplastic syndromes [8] and inflammation in bowel tissue and the central nervous system [9].